Cargando…
Patient-derived xenografts for individualized care in advanced sarcoma
BACKGROUND: Patients with advanced, metastatic sarcoma have a poor prognosis, and the overall benefit from the few standard-of-care therapeutics available is small. The rarity of this tumor, combined with the wide range of subtypes, leads to difficulties in conducting clinical trials. The authors pr...
Autores principales: | Stebbing, Justin, Paz, Keren, Schwartz, Gary K, Wexler, Leonard H, Maki, Robert, Pollock, Raphael E, Morris, Ronnie, Cohen, Richard, Shankar, Arjun, Blackman, Glen, Harding, Victoria, Vasquez, David, Krell, Jonathan, Ciznadija, Daniel, Katz, Amanda, Sidransky, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298787/ https://www.ncbi.nlm.nih.gov/pubmed/24705963 http://dx.doi.org/10.1002/cncr.28696 |
Ejemplares similares
-
Comparative mutational landscape analysis of patient-derived tumour xenografts
por: Brait, Mariana, et al.
Publicado: (2017) -
Reliable Establishment of Human Sarcoma Xenografts in the Nude Rat
por: Tinkey, Peggy T., et al.
Publicado: (1999) -
‘Being there' for women with metastatic breast cancer: a pan-European patient survey
por: Harding, V, et al.
Publicado: (2013) -
Patient-derived xenograft models—the future of personalised cancer treatment
por: Bhimani, Jenna, et al.
Publicado: (2020) -
Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023)